T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Sensata Technologies
ST
$6.72B
| $7.04M | ﹤0.01% |
121,427
-28,090
| -19% | -$1.62M |
|
1427
Restaurant Brands International
QSR
$26.7B
| $7M | ﹤0.01% |
107,762
| – | – |
|
1428
VICI Properties
VICI
$29B
| $6.99M | ﹤0.01% |
247,553
+57,153
| +30% | +$1.55M |
|
|
PSTH.WS
1429
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
| $6.94M | ﹤0.01% |
851,688
| – | – |
|
1430
Celldex Therapeutics
CLDX
$3.52B
| $6.84M | ﹤0.01% |
332,230
+39,162
| +13% | +$899K |
|
|
COHR
1431
DELISTED
Coherent Inc
COHR
| $6.74M | ﹤0.01% |
26,668
-51,116
| -66% | -$11.3M |
|
1432
HEICO Corp Class A
HEI.A
$38B
| $6.57M | ﹤0.01% |
57,811
-1,248
| -2% | -$145K |
|
1433
Under Armour
UAA
$2.3B
| $6.52M | ﹤0.01% |
294,066
-18,851
| -6% | -$394K |
|
1434
Precision BioSciences
DTIL
$201M
| $6.51M | ﹤0.01% |
+20,956
| New | +$7.34M |
|
|
MASI
1435
DELISTED
Masimo
MASI
| $6.44M | ﹤0.01% |
28,053
-1,461
| -5% | -$367K |
|
1436
Zscaler
ZS
$30.4B
| $6.38M | ﹤0.01% |
37,133
+2,238
| +6% | +$445K |
|
|
ELAT
1437
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $6.37M | ﹤0.01% |
139,505
+1,264
| +0.9% | +$60.7K |
|
1438
Jones Lang LaSalle
JLL
$17B
| $6.22M | ﹤0.01% |
34,716
-354
| -1% | -$57.7K |
|
1439
Annaly Capital Management
NLY
$17.6B
| $6.14M | ﹤0.01% |
178,573
+3,722
| +2% | +$126K |
|
1440
WillScot Mobile Mini Holdings
WSC
$4.17B
| $6.12M | ﹤0.01% |
220,356
-52,455
| -19% | -$1.38M |
|
|
SFIX
1441
Stitch Fix
SFIX
$487M
| $6.07M | ﹤0.01% |
122,536
+50,562
| +70% | +$3.56M |
|
1442
Jack in the Box
JACK
$358M
| $5.93M | ﹤0.01% |
53,983
-816
| -1% | -$83K |
|
1443
Carlisle Companies
CSL
$15.2B
| $5.91M | ﹤0.01% |
35,884
-553
| -2% | -$84.8K |
|
1444
Lear
LEA
$8.16B
| $5.88M | ﹤0.01% |
32,445
+879
| +3% | +$148K |
|
1445
Liberty Global Class C
LBTYK
$3.46B
| $5.85M | ﹤0.01% |
228,900
+1,100
| +0.5% | +$27.5K |
|
1446
Sunrun
RUN
$2.37B
| $5.77M | ﹤0.01% |
95,373
+27,600
| +41% | +$1.92M |
|
1447
US Foods
USFD
$24B
| $5.75M | ﹤0.01% |
150,788
+2,094
| +1% | +$75.7K |
|
1448
OGE Energy
OGE
$9.69B
| $5.71M | ﹤0.01% |
176,426
+7,434
| +4% | +$234K |
|
|
ADVM
1449
DELISTED
Adverum Biotechnologies
ADVM
| $5.71M | ﹤0.01% |
57,893
-107,850
| -65% | -$12.9M |
|
1450
Under Armour Class C
UA
$2.25B
| $5.52M | ﹤0.01% |
299,210
-20,150
| -6% | -$354K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.